Soothion Acne Treatment Formula

Manufacturer
Electrolyzed Innovations, LLC | TropiChem Research Labs, Inc.
Effective date
2019-12-23
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:02:16

Label at a glance#

ProductSoothion Acne Treatment Formula
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

For the treatment of Acne. Clears up acne pimples, blackheads and whiteheads and allows skin to heal.

Dosage and administration

clean the skin thoroughly before applying this product. cover the entire affected area with a thin layer one to three times a daily. because excessive drying of the skin may occur, start with one application daily, then gradually increase to two  or three times daily if needed or as directed by a doctor. if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Storage and handling

Store in a cool, dry place below 77°F Protect from heat and light

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 1%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Uses

INDICATIONS & USAGE SECTION

  • For the treatment of Acne.
  • Clears up acne pimples, blackheads and whiteheads and allows skin to heal.

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding ask a doctor before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • clean the skin thoroughly before applying this product.
  • cover the entire affected area with a thin layer one to three times a daily.
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two  or three times daily if needed or as directed by a doctor.
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other information

STORAGE AND HANDLING SECTION

  • Store in a cool, dry place below 77°F
  • Protect from heat and light

Inactive ingredients

INACTIVE INGREDIENT SECTION

melaleuca alternifolia leaf, polyacrylic acid, water

DESCRIPTION SECTION

Manufactured for Electrolyzed Innovations, LLC
(866) 528-3721    2214 Wilshire Dr, Piqua OH 45356 USA

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Ion Infused

Acne Treatment Formula

Soothion

Ion Disperson Formula Designed to Clear Up

  • Acne
  • Pimples
  • Blemishes
  • Whiteheads
  • Blackheads

Net Wt. 8 oz (240 mL)              Made in USA

Soothion Acne LabelSoothion Acne Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
245199salicylic acid 1 % Topical LotionPSN2
245199salicylic acid 10 MG/ML Topical LotionSCD2
245199salicylic acid 1 % Topical LotionSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69031-005-082022-01-28C16284748780-1d6a99b39-ecad-a426-e053-dadaa90af4c2Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69031-005-08Soothion Acne Treatment Formula226 g in 1 BOTTLELOTION2262

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69031-005SOOTHION ACNE TREATMENT FORMULA (SALICYLIC ACID) LOTION [ELECTROLYZED INNOVATIONS, LLC]2Legacy NDC, 1 package rows20191224_317ee6b7-995f-48c7-882c-a4a2f7938ae7.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZ1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ1
MELALEUCA ALTERNIFOLIA LEAFINACTIVE INGREDIENTG43C57162K1
POLYACRYLIC ACID (250000 MW)INACTIVE INGREDIENT9G2MAD7J6W1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69031-00569031-005-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 2 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
POLYACRYLIC ACID (250000 MW)POLYACRYLIC ACID (250000 MW)9G2MAD7J6WSYSTEM / TOPICAL196 mgExact identifier — unii candidate
2 equally ranked IID candidates
POLYACRYLIC ACID (250000 MW)POLYACRYLIC ACID (250000 MW)9G2MAD7J6WFILM, EXTENDED RELEASE / TRANSDERMALNAExact identifier — unii candidate
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9a6688da-92a4-2d72-e053-2995a90a536c317ee6b7-995f-48c7-882c-a4a2f7938ae72019-12-23WarningsExact identifier
spl id: 9a6688da-92a4-2d72-e053-2995a90a536c
spl set id: 317ee6b7-995f-48c7-882c-a4a2f7938ae7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.